Investigating endothelial cell transduction and hexon:PF4 binding of ChAdOx1 in the context of VITT.

Jcovden (COVID-19 vaccine (Ad26.COV2-S [recombinant])) - J&J

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/40516826

Alan L Parker; Charlotte Lovatt; Emma A Swift; Lars Frängsmyr; Rosie M Mundy

Jun 15, 2025